Genetic Engineering & Biotechnology News

NOV1 2018

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: https://gen.epubxp.com/i/1042256

Contents of this Issue

Navigation

Page 44 of 57

High-Throughput Multiplexed Screening of TCR Signaling Inhibitors T cells play a critical role in the adaptive immune response. In naive T cells, binding of the T-cell receptor (TCR) to peptides complexed with major histocompatibility complex triggers an intricate signaling mechanism leading to T-cell activation, proliferation, and production of cytokines. Modulating the TCR signaling pathway using biologics, small molecules, or genetic engineering is highly relevant to many therapeutic areas, including cancer immunotherapy, adoptive cell therapy, vaccine development, and autoimmune disease. The development of these drugs and therapies require the routine use of assays to profile T-cell function and health. Join us for this GEN webinar where we will discuss the importance of routine monitoring of T-cell function in drug discovery. Moreover, we will highlight the need for rapid immune-function monitoring and how this can be addressed by simultaneously measuring cell phenotype, T-cell activation markers, cell proliferation, cell viability, and quantifying secreted cytokines in a miniaturized assay format. Webinar Highlights • High-throughput screening of a library of kinase inhibitors for T-cell activation inhibition using primary human PBMCs • Evaluating CD69, CD25, and HLA-DR activation markers, cell proliferation and IFN-γ and TNF in a single multiplexed assay • Deriving actionable insights from powerful data analysis tools, such as heat maps and IC50 curves, and combining assay outcomes to help quickly locate hits using multiplexed criteria A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist. Free Registration! www.genengnews.com/TCR View It Now! On Demand DURATION: 60 minutes COST: Complimentary Speaker John O'Rourke, Ph.D. Head of Product Development Cell Analytics Produced with support from Webinars

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - NOV1 2018